ScholarWorks@Gachon: Hong, Ji Hyung

Detailed Information

Hong, Ji Hyung (홍지형)

Social Sciences (의료산업경영학과)

Research Area

Tel 031-750-5205
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

depression:4||SSRI:3||Depression:3||duloxetine:2||antidepressant:2||ICER:2||Cost:1||Discrimination:1||Duloxetine:1||EQ5D:1||Economic Evaluation Exemption:1||Economic Evaluation Exemption Procedure:1||End of life:1||Ethnic return migrants:1||Functioning:1||Gastric cancer:1||Gene therapies:1||Health care rationing:1||Health technology assessment:1||Highpriced:1||Highpriced medicine:1||Identity:1||Key Words : costeffectiveness threshold:1||Korean Chinese:1||Managed entry agreements:1||Middle East:1||National Health Insurance:1||Oncology drugs:1||Patient preference:1||Potential cures:1||Priority setting:1||Quality of life:1||Qualityadjusted life years:1||Risk Sharing Agreement (RSA):1||South Korea:1||Spending:1||Taiwan:1||Therapeutic value:1||VAS:1||adult socioeconomic status:1||childhood socioeconomic status:1||concentration index:1||deprivation:1||economic growth:1||elderly:1||functioning:1||health behaviors:1||immigrant:1||incomerelated inequality:1||inequality:1||life expectancy:1||life satisfaction:1||marginal productivity:1||mental health:1||opportunity costs:1||quality of life:1||regional disparity:1||selfrated health:1||subjective social status:1||suicide ideation:1||기회비용:1||지불의사:1||한계 생산성:1||Additional benefit:1||핵심용어: 비용효과 임계값:1||Age factors:1||Antidepressant:1||Burden of illness:1||COVID19:1||Comparative analysis:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE